Replies to post #2651 on Galectin Therapeutics Inc. (GALT)

[Chess Master]

The $50 mil CNAT deal moved to $6. Could see a similar reaction on a license deal. But man there are some shorts in there ahead of this announcement keeping this thing down. They are betting on the CEO being the lackluster speaker that he is. too bad for the shorts hes not speaking.